The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical Trial

Rationale: In the IMPACT (Informing the Pathway of Chronic Obstructive Pulmonary Disease Treatment) trial, fluticasone furoate (FF)/umeclidinium (UMEC)/vilanterol (VI) significantly reduced exacerbations compared with FF/VI or UMEC/VI in patients with symptomatic chronic obstructive pulmonary diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, MeiLan K., Criner, Gerard J., Dransfield, Mark T., Halpin, David M. G., Jones, C. Elaine, Kilbride, Sally, Lange, Peter, Lettis, Sally, Lipson, David A., Lomas, David A., Martin, Neil, Wise, Robert A., Singh, Dave, Martinez, Fernando J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605201/
https://www.ncbi.nlm.nih.gov/pubmed/32584168
http://dx.doi.org/10.1164/rccm.201912-2478OC

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605201/
https://www.ncbi.nlm.nih.gov/pubmed/32584168
http://dx.doi.org/10.1164/rccm.201912-2478OC

Ejemplares similares